CVS reported earnings that beat estimates and raised its guidance, driven by continued improvements in its insurance division. The company also announced a partnership with Eli Lilly to make Zepbound and Foundayo available through the CVS Health app.
Impact: The upbeat earnings and new partnership are likely to lift CVS’s share price in the short term.
Not investment advice